The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).
Patients underwent a cardiac MRI examination with Dotarem within 60 days after screening visit. The myocardial CCTA examination with Xenetix 350 was performed within 1 to 30 days (but no sooner than 24 hours) after the MRI examination.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
351
Xenetix 350 was administered at a dose up to 180 ml, according to the patient's body weight measured on the day of administration.
Dotarem was administered at a dose of 0.1 mmol/kg body weight (0.2 ml/kg body weight)
Asan Medical Center
Seoul, South Korea
Prevalence of Occult Myocardial Scar on Delayed-enhanced MRI in Asymptomatic Patients With Type 2 Diabetes Mellitus
Time frame: From 1 week to 2 months (after the collection of data corresponding to cardiac MRI and CCTA examinations)
Number of Patients With and Without Occult Myocardial Scar on Cardiac MRI According to the Degree of Stenosis
The degree of coronary artery stenosis on CCTA was assessed according to the following scale: * No stenosis: 0% * Non significant stenosis: 1-50% * Significant stenosis \>50% and ≤99% * Occlusion: 100%
Time frame: From 1 week to 2 months (after the collection of data corresponding to cardiac MRI and CCTA examinations)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.